全文获取类型
收费全文 | 22270篇 |
免费 | 1985篇 |
国内免费 | 680篇 |
专业分类
耳鼻咽喉 | 253篇 |
儿科学 | 472篇 |
妇产科学 | 489篇 |
基础医学 | 2773篇 |
口腔科学 | 411篇 |
临床医学 | 1627篇 |
内科学 | 4769篇 |
皮肤病学 | 461篇 |
神经病学 | 1185篇 |
特种医学 | 354篇 |
外国民族医学 | 1篇 |
外科学 | 3148篇 |
综合类 | 2704篇 |
一般理论 | 1篇 |
预防医学 | 1293篇 |
眼科学 | 232篇 |
药学 | 2345篇 |
4篇 | |
中国医学 | 727篇 |
肿瘤学 | 1686篇 |
出版年
2024年 | 43篇 |
2023年 | 361篇 |
2022年 | 1125篇 |
2021年 | 1549篇 |
2020年 | 1097篇 |
2019年 | 1543篇 |
2018年 | 1601篇 |
2017年 | 991篇 |
2016年 | 691篇 |
2015年 | 865篇 |
2014年 | 1483篇 |
2013年 | 1351篇 |
2012年 | 1141篇 |
2011年 | 1319篇 |
2010年 | 1027篇 |
2009年 | 912篇 |
2008年 | 893篇 |
2007年 | 929篇 |
2006年 | 747篇 |
2005年 | 627篇 |
2004年 | 555篇 |
2003年 | 557篇 |
2002年 | 334篇 |
2001年 | 280篇 |
2000年 | 256篇 |
1999年 | 245篇 |
1998年 | 343篇 |
1997年 | 268篇 |
1996年 | 188篇 |
1995年 | 156篇 |
1994年 | 131篇 |
1993年 | 92篇 |
1992年 | 95篇 |
1991年 | 81篇 |
1990年 | 52篇 |
1989年 | 57篇 |
1988年 | 68篇 |
1987年 | 43篇 |
1986年 | 48篇 |
1985年 | 93篇 |
1984年 | 114篇 |
1983年 | 73篇 |
1982年 | 98篇 |
1981年 | 78篇 |
1980年 | 80篇 |
1979年 | 74篇 |
1978年 | 49篇 |
1977年 | 32篇 |
1976年 | 29篇 |
1975年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
目的探讨重睑术中采用经重睑切口的上睑旋转皮瓣矫正轻、中度内眦赘皮的疗效。方法回顾分析 2016 年 7 月—2017 年 10 月,重睑术中采用经重睑切口的上睑旋转皮瓣矫正轻、中度睑板型内眦赘皮合并单睑的 34 例患者(试验组)临床资料;以同期 38 例接受传统“Z”成形内眦开大术联合重睑术患者为对照(对照组)。两组患者年龄及内侧赘皮分度比较,差异无统计学意义(P>0.05)。于术前及术后 6 d、6 个月测量眼裂长度,计算眼裂长度改善程度;参照内眦赘皮矫正标准评价手术疗效。 结果两组患者切口均Ⅰ期愈合,并获随访 6 个月。两组内眦赘皮明显矫正。试验组内眦处无切口;对照组遗留瘢痕,其中 6 例增生明显。术后 6 d 试验组及对照组眼裂长度改善程度分别为 3.63%±0.07%、3.70%±0.05%;术后 6 个月分别为 4.64%±0.09%、4.46%±0.10%;两组比较差异均无统计学意义(t=0.005,P=0.996;t=0.287,P=0.871)。术后 6 个月疗效评价,试验组优 20 例、良 12 例、差 2 例,优良率 94.12%;对照组优 16 例、良 16 例、差 6 例,优良率 84.21%;差异无统计学意义(χ2=0.796,P=0.372)。 结论经重睑切口的上睑旋转皮瓣矫正轻、中度内眦赘皮手术操作简便、效果满意,内眦处无瘢痕形成。 相似文献
42.
《Journal of infection and chemotherapy》2020,26(1):23-27
IntroductionAlthough peak C-reactive protein (CRP) levels are correlated with the prognosis of some diseases, there have been no reports regarding the association between peak CRP levels and mortality in patients with bacteremia. The present study aimed to determine the association between peak CRP levels and prognosis in patients with bacteremia.MethodsThis retrospective cohort study was conducted in a single tertiary hospital and included patients with bacteremia admitted to the emergency department from November 2012 to March 2017. Cox regression analysis was performed to examine the association between peak CRP levels and 30-day mortality. We also performed propensity score adjustment using potential confounding factors.ResultsOne hundred fifty-nine patients were included in the study. Peak CRP levels were significantly higher in the β-hemolytic streptococci (P = 0.001) and Streptococcus pneumoniae (P = 0.003) groups. The C-statistic of the multivariate logistic regression model for the propensity score was 0.88. For 30-day mortality, peak CRP levels >20 mg/dL did not show significance in the Cox regression analysis (hazard ratio, 0.866; 95% confidence interval, 0.489–1.537; P = 0.62). Even after propensity score adjustment, no significance was noted (hazard ratio, 0.865; 95% confidence interval, 0.399–1.876; P = 0.71).ConclusionsPeak CRP levels were not an independent predictor of mortality in patients with bacteremia in the emergency department. Clinicians should consider that patients with extremely high peak CRP levels do not necessarily have high mortality and vice versa. 相似文献
43.
Béla Nagy Zsolt Bene Zsolt Fejes Sonya L. Heltshe David Reid Nicola J. Ronan Yvonne McCarthy Daniel Smith Attila Nagy Elizabeth Joseloff György Balla János Kappelmayer Milan Macek Scott C. Bell Barry J. Plant Margarida D. Amaral István Balogh 《Journal of cystic fibrosis》2019,18(2):271-277
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献44.
驱动基因的发现及针对驱动基因的靶向治疗已显著提高了肺癌患者的生存质量和时间,但目前对于BRAF、HER2、MET、RET等少见驱动基因改变肺癌患者的靶向药物的选择仍然较少。近年来免疫检查点抑制剂在肺癌治疗中取得了一定的疗效,但因为少见驱动基因突变的肺癌患者本身样本量少,开展大规模临床随机对照试验尚存在一定的困难,目前此类患者接受免疫检查点抑制剂治疗的疗效情况仍不明确。本文将对目前已掌握的免疫检查点抑制剂治疗BRAF、HER2、MET、RET等少见驱动基因改变肺癌患者的临床研究结果进行综述,以期在一定程度上为临床工作提供一些依据和参考。 相似文献
45.
目的治疗顽固性下颌磨牙根尖周炎。并尽量减少对牙周膜的机械性损伤。方法采用下牙槽神经阻滞麻醉,并配合局部麻醉。拔牙钳的尖置放于釉牙骨质界以上,采用颊舌向摆动的方式将患牙拔下。在不断滴有生理盐水的条件下,立即用高速车针磨除患牙根尖2 ̄3mm的牙体组织,根管内3 ̄5mm深的充填物要用圆钻将其清除,再用牙胶尖和氢氧化钙糊剂充填。将患牙再植入牙槽窝之前,务必用生理盐水将牙槽窝冲洗干净,要求严格控制在15分钟内完成再植,并尽量减少对牙周膜的机械性损伤。再植牙齿一般不需要夹板固定,必要时可采用缝线缝合固定。结果我们选择的5例患者,术后随访1 ̄2年,1例患者再植失败,4例患者再植成功。结论特异性再植术治疗顽固性下颌磨牙根尖周炎疗效理想,而且较易掌握。 相似文献
46.
仙草消毒液为含 3 0 %乙醇的植物消毒剂 ,其中包括五味子、细辛、丁香等成分 ,p H6.0 1。为了解其杀灭微生物效果及其毒性 ,进行了载体定量杀菌试验及毒性试验。结果 ,1∶ 1的水稀释液对金黄色葡萄球菌作用2分钟 ,1∶ 2的稀释液对金黄色葡萄球菌作用 8分钟 ,以其原液对白色念珠菌作用 2 min,平均杀灭率均大于99.90 %。小牛血清对其杀灭效果有影响 ,原液经 5 4℃存放 14天 ,杀菌效果无明显变化。以其原液对雌、雄小鼠经口 LD50 >5 0 0 0 mg/Kg,对大耳白兔一次眼、皮肤刺激试验平均积分指数为 0 ,微核试验阴性 ,蓄积毒性试验为弱蓄积毒性 相似文献
47.
48.
49.
50.
P B Schneider U Denk M Breitenbach K Richter P Schmid-Grendelmeier S Nobbe M Himly A Mari C Ebner B Simon-Nobbe 《Clinical and experimental allergy》2006,36(12):1513-1524
BACKGROUND: Alternaria alternata is one of the most important allergenic fungi worldwide. Mannitol dehydrogenase (MtDH) has previously been shown to be a major allergen of Cladosporium herbarum and cross-reactivity has been demonstrated for several fungal allergens. OBJECTIVE: The present study's objective was to clone the MtDH from an A. alternata cDNA library, express and purify the recombinant non-fusion protein and test its IgE-binding properties. Methods A cDNA library prepared from A. alternata hyphae and spores was screened for mannitol dehydrogenase by DNA hybridization with the radioactively labelled C. herbarum homologue as a probe. The resulting clone was sequenced and heterologously expressed in Escherichia coli as a recombinant non-fusion protein, which was purified to homogeneity and analysed for its IgE-binding capacity. RESULTS: The coding sequence of the full-length cDNA clone comprises 798 bp encoding a protein with a molecular mass of 28.6 kDa and a predicted pI of 5.88. Protein sequence analysis revealed an identity of 75% and a homology of 86% between the MtDHs of A. alternata and C. herbarum. The functional mannitol dehydrogenase was expressed in the E. coli strain BL21(DE3) transformed with the vector pMW172 and purified to homogeneity. The enzyme catalyses the NADPH-dependent conversion of d-fructose to d-mannitol. In IgE-ELISA and immunoblots, MtDH is recognized by 41% of A. alternata-allergic patients. In vivo immunoreactivity of the recombinant MtDH was verified by skin prick testing. Finally, inhibition-ELISA experiments confirmed cross-reactivity between the MtDHs of A. alternata and C. herbarum. CONCLUSION: Mannitol dehydrogenase (Alt a 8) represents an important new allergen of the ascomycete A. alternata that might be suitable for improving diagnostic and therapeutic procedures. 相似文献